Mercaptopurine 50 mg contains 6-Mercaptopurine (6-MP), a purine analog antimetabolite widely used in the treatment of leukemia. It is typically administered orally as part of combination chemotherapy protocols, especially during the maintenance phase of leukemia treatment.

🔬 Mechanism of Action

Mercaptopurine works by mimicking purine bases used in DNA and RNA synthesis. Once metabolized inside the body, it inhibits purine nucleotide synthesis and incorporates into DNA and RNA. As a result, it disrupts cell replication and leads to the death of rapidly dividing cancer cells.

💊 Indications

Mercaptopurine Tablets 50 mg are indicated for:

• Acute Lymphoblastic Leukemia (ALL)
• Maintenance therapy in leukemia treatment protocols
• Other hematologic malignancies as prescribed by a specialist

📌 Key Features of Mercaptopurine Tablets 50 mg

• Strength: 50 mg
• Dosage Form: Oral tablet
• Therapeutic Class: Antimetabolite / Purine Analog Chemotherapy
• Administration: Taken orally as prescribed, usually once daily
• Monitoring: Regular blood counts and liver function tests required

⚕️ Benefits of Mercaptopurine Tablets 50 mg

• Essential component of leukemia maintenance therapy
• Helps prevent relapse in ALL
• Oral administration for convenient long-term treatment
• Well-established therapy in pediatric and adult oncology

⚠️ Precautions

• Risk of bone marrow suppression (anemia, neutropenia, thrombocytopenia)
• Potential liver toxicity
• Drug interactions may occur with certain medications
• Genetic enzyme deficiency (TPMT) may increase toxicity risk
• Use strictly under hematologist/oncologist supervision

Mercaptopurine Tablets 50 mg is a cornerstone medication in leukemia treatment protocols, helping maintain remission and improve long-term survival outcomes when used under expert medical guidance.